-+ 0.00%
-+ 0.00%
-+ 0.00%

Penn Medicine, IBA form Noventra Oncology Alliance proton therapy joint venture

PUBT·09/28/2026 05:01:11
Listen to the news
Penn Medicine, IBA form Noventra Oncology Alliance proton therapy joint venture
  • Penn Medicine formed Noventra Oncology Alliance with IBA to support global development of proton therapy, radiation oncology programs.
  • Services span strategy, financial planning, clinical readiness, implementation, long-term operational performance across the care delivery lifecycle.
  • Venture combines Penn Medicine’s clinical, operational, research expertise with IBA’s proton therapy technology, project development, implementation capabilities.
  • Platform targets lower clinical, operational, financial risk for providers investing in advanced radiation oncology programs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IBA - Ion Beam Applications SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609280100OMX_____CNEWS_EN_GNW1001274815_en) on September 28, 2026, and is solely responsible for the information contained therein.